Inflammatory dilated cardiomyopathy : Etiology and clinical management.

Its intermediate results from the immunosuppressive treatment arm demonstrated a positive trend in ejection fraction and major adverse cardiac events after 6 months of treatment and a significant benefit after 1 year of follow-up [ 72 ].

also in 11,005 other papers